Pharmacogenomic Testing
J6 · Effective Jul 13, 2025
20 active Medicare policies list J42, and 4 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J6 · Effective Jul 13, 2025
JK · Effective Jul 13, 2025
J9 · Effective Dec 12, 2021
JH · Effective Dec 12, 2021
JL · Effective Dec 12, 2021
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
National · Effective Oct 1, 2026
4 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of J42 |
|---|---|---|
| Analysis of Volatile Organic Compounds | Oct 3, 2023 | Covered |
| Chest Physiotherapy and Airway Clearance Devices | Mar 17, 2023 | Covered |
| Extracorporeal Photochemotherapy (Photopheresis) | Mar 29, 2023 | Covered |
| Policy | Effective | Status of J42 |
|---|---|---|
| Pulmonary Function Testing | Not recorded | Covered |
National · Effective Oct 1, 2026
J6 · Effective Apr 1, 2026
National · Effective Jun 4, 2026
National · Effective Oct 1, 2026
J6 · Effective Apr 1, 2026
JL · Effective Sep 10, 2026
J9 · Effective Sep 10, 2026
National · Effective Oct 1, 2026
National · Effective Jan 1, 2026
National · Effective Feb 1, 2026